In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilms

Antimicrob Agents Chemother. 2014;58(2):1183-6. doi: 10.1128/AAC.01745-13. Epub 2013 Nov 11.

Abstract

Candida albicans biofilms are generally considered to be resistant to azole antifungal agents but susceptible to echinocandins. We demonstrate that in a sequential therapy regimen, treatment with fluconazole first followed by caspofungin leads to a significant decrease of the efficacy of this echinocandin. Cellular stress responses induced by high fluconazole concentrations and mediated by Hsp90 and calcineurin play an important role in this phenomenon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptation, Physiological / genetics
  • Antifungal Agents / pharmacology*
  • Biofilms / drug effects*
  • Biofilms / growth & development
  • Calcineurin / genetics
  • Calcineurin / metabolism
  • Candida albicans / drug effects
  • Candida albicans / genetics
  • Candida albicans / metabolism
  • Caspofungin
  • Echinocandins / pharmacology*
  • Fluconazole / pharmacology*
  • Fungal Proteins / genetics*
  • Fungal Proteins / metabolism
  • Gene Expression Regulation, Fungal*
  • HSP90 Heat-Shock Proteins / genetics
  • HSP90 Heat-Shock Proteins / metabolism
  • Lipopeptides
  • Microbial Sensitivity Tests
  • Stress, Physiological / genetics
  • Time Factors

Substances

  • Antifungal Agents
  • Echinocandins
  • Fungal Proteins
  • HSP90 Heat-Shock Proteins
  • Lipopeptides
  • Fluconazole
  • Calcineurin
  • Caspofungin